Landos BiopharmaLABP
13F holders, Q1 2024 (March 31)15holders
1famous investor
$21.52avg. 13F price*
At the end of Q1 2024, 15 institutions reported holding Landos Biopharma Inc. (LABP) in their 13F filings. The largest holders were Perceptive Advisors LLC ($31.9M), Deltec Asset Management LLC ($1.1M) and Renaissance Technologies ($406K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Landos Biopharma Inc.
- CUSIP
- 515069201
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.9M |
| Exits | 1 | $154 |
Ownership 15 holders
| Perceptive Advisors LLC | 0.56% | No change | 1,486,991 | $31.9M |
| Deltec Asset Management LLC | 0.21% | New | 50,000 | $1.1M |
| Renaissance Technologies | 0.00% | Add +67.8% | 18,890 | $406K |
| Macquarie Group Ltd. | 0.00% | No change | 14,718 | $316K |
| Virtu Financial LLC | 0.02% | New | 14,537 | $313K |
| Geode Capital Management, LLC | 0.00% | No change | 12,604 | $271K |
| PenderFund Capital Management Ltd. | 0.14% | New | 9,300 | $271K |
| Black Maple Capital Management LP | 0.15% | New | 10,405 | $223K |
| UBS Group AG | 0.00% | Add +9623.8% | 4,084 | $88K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 896 | $19K |
| Acadian Asset Management LLC | 0.00% | No change | 134 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 59 | $1K |
| Royal Bank of Canada | 0.00% | New | 61 | $1K |
| Morgan Stanley | 0.00% | New | 13 | $279 |
| Wells Fargo & Company | 0.00% | No change | 10 | $215 |
"% of holder's portfolio" is LABP's weight in each manager's 13F, not the share of Landos Biopharma Inc. the manager owns.